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Abstract 
Background: The spread of artemisinin-resistant Plasmodium falciparum is a global health concern. Myanmar stands 
at the frontier of artemisinin-resistant P. falciparum. Myanmar also has the highest reported malaria burden in South-
east Asia; it is integral in the World Health Organization’s plan to eliminate malaria in Southeast Asia, yet few epidemio-
logical data exist for the general population in Myanmar.
Methods: This cross-sectional, probability household survey was conducted in Phyu township, Bago Region (central 
Myanmar), during the wet season of 2013. Interviewers collected clinical and behavioural data, recorded tympanic 
temperature and obtained dried blood spots for malaria PCR and serology. Plasmodium falciparum positive samples 
were tested for genetic mutations in the K13 region that may confer artemisinin resistance. Estimated type-specific 
malaria PCR prevalence and seroprevalence were calculated, with regression analysis to identify risk factors for sero-
positivity to P. falciparum. Data were weighted to account for unequal selection probabilities.
Results: 1638 participants were sampled (500 households). Weighted PCR prevalence was low (n = 41, 2.5%) and 
most cases were afebrile (93%). Plasmodium falciparum was the most common species (n = 19. 1.1%) and five (26%) 
P. falciparum samples harboured K13 mutations. Plasmodium knowlesi was detected in 1.0% (n = 16) and Plasmodium 
vivax was detected in 0.4% (n = 7). Seroprevalence was 9.4% for P. falciparum and 3.1% for P. vivax. Seroconversion to P. 
falciparum was 0.003/year in the whole population, but 16-fold higher in men over 23 years old (LR test p = 0.016).
Discussion: This is the first population-based seroprevalence study from central Myanmar. Low overall prevalence 
was discovered. However, these data suggest endemic transmission continues, probably associated with behavioural 
risk factors amongst working-age men. Genetic mutations associated with P. falciparum artemisinin resistance, the 
presence of P. knowlesi and discrete demographic risk groups present opportunities and challenges for malaria con-
trol. Responses targeted to working-age men, capable of detecting sub-clinical infections, and considering all species 
will facilitate malaria elimination in this setting.
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Background
The last decade has seen global progress in malaria 
control [1, 2]. This is threatened by the emergence of 
Plasmodium falciparum resistant to artemisinin, the 
world’s front-line anti-malarial [3]. So far, P. falcipa-
rum with reduced susceptibility to artemisinin has been 
described in Cambodia, Thailand, Vietnam, Laos and 
Myanmar [4–7]. The World Health Organization (WHO) 
recently set its sights on malaria elimination in Southeast 
Asia in order to contain this threat [2]. The emergence of 
the zoonotic primate malaria Plasmodium knowlesi as a 
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parasite of significant public health importance in Malay-
sian Borneo complicates elimination [8, 9]; the distribu-
tion and prevalence of this species in other countries in 
the region remains uncertain.
Myanmar is reported to account for the vast majority 
of malaria cases and deaths within Southeast Asia [10]. 
Better understanding the epidemiology of malaria here 
would likely contribute to successful elimination. Malaria 
distribution in Myanmar is heterogeneous; forests are a 
major environmental factor driving patterns of disease 
[11, 12] and international and internal migration are also 
risk factors [13, 14]. Whilst transmission is relatively well 
documented in border areas [13], few data exist from 
central Myanmar and the burden and drivers of infection 
in this area remain poorly understood.
Light microscopy and rapid diagnostic tests (RDTs) 
underestimate the prevalence of infection with Plas-
modium spp, particularly in low-endemic settings [15]. 
Polymerase chain reaction (PCR) is more sensitive in 
detecting current infection and allows further testing 
such as for drug resistance-associated mutations [16]. 
Serological methods have been shown to reliably esti-
mate malaria transmission and can identify risk factors 
with achievable sample sizes in low prevalence areas [17]. 
Prevalence of antibodies to specific malaria antigens, 
which indicate malaria exposure, can be used to calcu-
late the seroconversion rate (SCR, equivalent to the force 
of infection) [18]. Changes in SCR over time are of par-
ticular utility in monitoring the success of public health 
campaigns.
This study combined highly sensitive PCR testing 
and serological evidence of transmission intensity in a 
household survey in central Myanmar with collection of 
detailed epidemiological data to investigate the preva-
lence of, and risk factors for, malaria exposure.
Methods
Study site and population
Phyu is the largest township in Eastern Bago Region. 
Phyu is located on the main highway between Yangon 
(largest city) and Nay Pyi Taw (capital). It is 100 km west 
of the border with Thailand, and lies on a plain (high-
est altitude =  60  m) between forest-covered mountains 
(Fig.  1). The forests attract migrant labour for logging, 
charcoal production and agro-forestry [14]. Phyu was 
selected for this study due to its relatively large size and 
location on busy transport routes near forests. The pop-
ulation is approximately 250,000, of whom 89% live in 
semi-urban or rural areas, with 11% in Phyu town.
Medical services vary from a 50-bed township hospi-
tal to sub-rural health centers with no inpatient facilities. 
The latter cover 5–15 villages each with a midwife who 
provides basic services including malaria prevention. The 
township malaria inspector and local midwives accompa-
nied the team for this study.
The monsoon begins in May and ends in October; pre-
cipitation is heaviest in August (approximately 450 mm/
month). Peaks in malaria transmission follow the rains 
by 1–2 months. This study was conducted in August and 
September 2013.
Field procedures
Sample size calculation
A required sample size of 1174 was calculated, assuming 
a malaria prevalence of 1 per 1000, with 95% confidence 
with 80% power; sampling 0.1% of the population, with a 
presumed design effect of 2 and a non-response rate of 
15%. Since the average household size in Myanmar is 4.7, 
30 clusters of 20 houses (~75 participants) were chosen 
(n = 1500).
Sampling technique
This cross-sectional study used a multistage cluster ran-
dom sample design. Administrative wards were the pri-
mary sampling unit, with villages and houses as the 
secondary and tertiary sampling units. 26 of 61 wards 
were included (population = 152,651, 60.2% of the total). 
The remaining wards (population = 101,078, 39.8%) were 
defined as inaccessible by vehicle by the local govern-
ment, necessitating exclusion. The included wards were 
weighted according to population size and randomly 
selected.
From each selected ward, villages were selected at ran-
dom with no population weighting. If a ward was selected 
more than once, more than one village was selected. 
Each selected village represented one cluster. A map was 
drawn by village leaders and houses were selected by sys-
tematic interval sampling and mapped using a Global 
Positioning System. Houses with no response were not 
revisited, the house with the closest street entrance was 
sampled in its place.
Questionnaires
Questionnaires were adapted from publicly available 
malaria indicator survey toolkits [19]. Pre-tested question-
naires were administered by pairs of community health-
care workers trained for this study. Households were 
defined as the group of people who had slept under the 
same roof the previous night and who shared a common 
entrance to the street. Household questionnaires recorded 
household structure, assets and demographic information 
for every household member, including those absent. Indi-
vidual questionnaires recorded self-reported forest expo-
sure, malaria symptoms and malaria prevention practices.
Participants were categorized as having exposure to 
forest if their occupation involved forest-related work 
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(forestry, farming, labouring) or if they reported visit-
ing the forest within the previous 6 months. Households 
were classified as having universal coverage of bed nets 
if they reported having at least 1 net per 2 people. Socio-
economic status (SES) was calculated using principal 
components analysis including household structure and 
assets. The derived score was divided into tertiles.
Clinical samples
Tympanic temperature was measured for all partici-
pants. Febrile participants (≥37.5  °C) were tested using 
RDT (SD Bioline Malaria Ag Pf/Pan) and referred for 
treatment. Capillary blood samples were spotted directly 
onto Whatman 3MM filter paper for all participants over 
6 months old regardless of tympanic temperature. Blood 
spots were air-dried, sealed with silica gel and sent to the 
London School for Hygiene and Tropical Medicine for 
storage at −20 °C before analysis.
Ethical approval
The study received approval from the Research Ethics 
Committee of University College London, the Myanmar 
Ministry of Health and Department of Medical Research, 
Lower Myanmar. Local and regional authorities were 
informed. Informed consent was obtained from all adults 
and from guardians of children aged under 15. For those 
aged between 15 and 18, informed consent from both 
parent and child was obtained.
Laboratory procedures
Serological analysis
Recombinant proteins: Plasmodium falciparum and 
Plasmodium vivax antigens MSP-119 were expressed in 
Escherichia coli as glutathione S-transferase-fusion pro-
teins [20] (Pv provided by A. Holder). PfAMA1_3D7 and 
PvAMA1_Sal1 were expressed as His-tagged proteins 
[21, 22].
Detection of anti-malarial antibodies by ELISA: IgG 
antibodies to each recombinant protein were assessed 
by ELISA as previously described [23]. Briefly, recombi-
nant antigens were coated overnight at 4 °C at the follow-
ing concentrations: PfAMA-1 at 0.5  μg/ml, PfMSP-119 
at 0.18  μg/ml, PvAMA-1 at 1  μg/ml and PvMSP-119 at 
1.8  μg/ml. Plates were washed using PBS plus 0.05% 
Tween 20 (PBS/T) and blocked with 1% skimmed milk 
powder in PBS/T. Samples and positive control sera (a 
pool of hyperimmune serum collected from a malaria 
endemic area) were tested in duplicate at 1/1000 and 
1/2000 dilutions against MSP and AMA, respectively. 
After washing, horseradish peroxidase-conjugated 
Fig. 1 Study site with GPS points (circles) demarcating each village cluster
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polyclonal rabbit anti-human IgG (Dako, Glostrup, Den-
mark) diluted at 1:5000 in PBS/T was added to all wells. 
All plates were developed using OPD substrate (OPD, 
sigma fast) and reactions were stopped with 2 M H2SO4. 
Plates were read at 492 nm and optical density (OD) val-
ues were recorded. Seropositivity was determined using 
a finite mixture model to define a cut-off value as previ-
ously described [18].
PCR analysis
Parasite DNA from blood spots was extracted using the 
Chelex method [24]. PCR amplifications targeting the 
18S rRNA gene was performed for initial screening for 
Plasmodium infections, using published PCR reactions 
and protocols with minor modifications [8]. PCR-posi-
tive samples were subsequently tested using an additional 
method targeting the cytochrome B gene (cytb) designed 
for the current study. The primer sets for the hemi-nested 
cytb assay were as follows: PgCytbF1 (5′-GAATTATG 
GAGTGGATGGTG-3′) and PgCytbR1 (5′-ACATC 
CAATCCATAATAAAGC-3′) for nest 1 and PgCytbF1 
and PgCytbR2 (5′-TTTTAACATTGCATAAAATGG-3′) 
for nest 2. Amplification cycling conditions were 95 °C 
for 3  min and then 30 cycles of 3 steps PCR, with 30  s 
annealing at 55  °C (nest 1) or 58  °C (nest 2) and elon-
gation at 72 °C for 1  min. Nested products were then 
characterized by direct sequencing for species determi-
nation. Polymorphisms at the propeller domain of the 
Kelch 13 (K13) encoded by the P. falciparum k13 gene 
(PF3D7_1343700) were also determined on P. falciparum 
PCR-positive isolates, using previously described proto-
cols for nested PCR methods and DNA sequencing [25].
Microscopic analysis
Thick and thin blood films were taken from each par-
ticipant. Giemsa-stained thick malaria films were exam-
ined under a 100×  oil-immersion lens. Samples were 
counted as negative if no parasite was seen after counting 
400 white blood cells. Samples were counted as positive 
if one or more parasites were seen—the corresponding 
thin films were then examined with a 100× oil-immer-
sion lens for speciation. All microscope slides were read 
in duplicate by technicians blinded to other reader’s 
findings.
Data analysis
Weighted prevalence of malaria species by PCR and sero-
logical status was estimated with 95% confidence inter-
vals using the Stata survey commands (v14, Statacorp, 
Texas).
To investigate transmission dynamics in the popula-
tion, a simple reversible catalytic conversion model was 
fitted to the age-seroprevalence data using maximum 
likelihood methods as previously described [17]. The 
model fits age-seroprevalence curves and estimates sero-
conversion rate (SCR) as analogous to the force of infec-
tion. Profile likelihood plots were used to test for any step 
change in SCR and, if present, identify the most likely 
age at which this occurred [26]. Models with two SCRs 
instead of one were assumed if the likelihood ratio com-
paring models indicated a statistically significant change 
(p < 0.05).
Univariate and multivariate logistic regression was 
used to investigate the relationship between gender, age, 
ethnicity, bed net ownership, SES, forest exposure, and 
seropositivity to P. falciparum antigens.
Results
A total of 701 houses in 27 clusters (villages) across 14 
administrative wards were visited, of which 500 houses 
had at least one resident present. Of the 2112 recorded 
residents of consenting households, 474 (22.4%) were 
absent (Table 1). 1638 were present and all consented to 
take part in the study.
The median age was 30 years (range 6 months-88 years) 
and 55% were female. 43% (57% of men and 27% of women) 
were classified as having had forest exposure (Table  1). 
80% of households were classified as having universal bed 
net coverage, but very few households were reported as 
having been sprayed with insecticide in the past year (3%). 
The majority of participants were of Burmese origin (63%) 
whilst people of Indian origin represented 33% of the sam-
ple and Shan origin 3%. Absent household residents were 
more likely to be male and less likely to be Indian com-
pared to those included in the study.
Malaria indicators
41 participants were found to have current infec-
tion when tested post hoc by PCR (2.6%, CI 1.5–4.3) 
(Table  2). The most common species detected was P. 
falciparum (1.1%, n = 19), followed by P. knowlesi (1.0%, 
n =  16). Plasmodium vivax (0.5%, n =  7) and Plasmo-
dium malariae (0.08%, n = 1) (Fig. 2). Only two mixed 
infections were detected. Three infected individuals 
were febrile (one each of P. falciparum, P. knowlesi and P. 
vivax), the remaining 38 were afebrile (93%). No infected 
individuals reported any other malaria symptoms and 
none had sought treatment for malaria in the past three 
months. 89 febrile people were tested with an RDT and 
none were found positive, including three PCR-con-
firmed infections. P. falciparum and P. knowlesi infec-
tions were found in all age groups. Plasmodium knowlesi 
was most common between ages 5 and 15. Plasmodium 
vivax was only detected in those aged 15 and above.
5 of the 19 (26.3%) P. falciparum samples harboured 
non-synonymous propeller domain mutations in 
Page 5 of 10Ghinai et al. Malar J  (2017) 16:16 
pfk13 (K13). These included the known variant Val534Ala 
[27] and four novel variants: Arg539Val, Asn572Asp, 
Glu602Gly, and Glu620Gly.
9.4% (n = 150) individuals were seropositive to P. fal-
ciparum antigens whilst 3.1% (n  =  50) were seroposi-
tive to P. vivax antigens. Of the 50, 19 (38%) were also 
positive to P. falciparum, indicating exposure to both 
species. Seropositivity to both P. falciparum and P. vivax 
was higher in men than women for both species (p 
value = 0.018 and 0.063 respectively).
Microscope slide positivity had high inter-observer 
variability, in part due to water damage and fungal con-
tamination of slides, and the microscopy results were 
therefore not included in the analysis.
Risk factors for exposure to malaria
Analysis of risk factors for malaria was restricted to 
seropositivity to P. falciparum due to the low numbers 
of infections detected by PCR. After adjusting for all 
other variables, seropositivity was more likely for men, 
[adjusted OR (AOR) 2.1 (1.3–3.4), p  =  0.006], and less 
likely for those with higher SES [AOR 0.6 (0.3–0.9), 
p  =  0.072], and of Indian origin  [AOR 0.3 (0.1–0.8)]. 
There was a strong association between seropositiv-
ity and forest exposure in the unadjusted model, which 
was lost after adjusting for gender, age, ethnicity and SES 
(Table  3). Migration status (moving to Phyu within the 
last 10  years or visiting outside Phyu in the preceding 
3  months) was not associated with an increased risk of 
malaria exposure in either the crude or adjusted analysis.
Serological estimates of malaria transmission
A reversible catalytic model and profile likelihood plots 
were used to investigate whether there was evidence for 
two SCRs, indicative of two discrete levels of exposure 
within the population. For P. falciparum, there was a 
clear peak in profile likelihood plot at age 23 years, indi-
cating a change in SCR (Fig.  3a). A model allowing for 
two SCRs fitted the data significantly better than a model 
with a single SCR (p = 0.016) (Fig. 3b).
When analysed separately by gender, a model with 
two SCRs fitted better for men (p = 0.004) whilst a sin-
gle SCR fit better for women (p  =  0.548) (Fig.  4). The 
SCR in men over the age of 23 was 0.050 (0.010–0.251) 
Table 1 Demographic characteristics of study participants
Study population
n %
Total 1638 100
Gender
 Males 752 45.9
 Female 886 54.1
Age
 0–5 163 9.9
 6–15 324 19.8
 16–25 255 15.6
 26–50 550 33.6
 51–100 346 21.1
Ethnicity
 Burmese 1086 64.1
 Indian 507 33.0
 Shan 45 2.9
Socioeconomic status
 Lowest 513 32.4
 Middle 549 34.6
 Highest 523 33.0
Work in or visit forest
 Yes 671 41.0
 No 967 59.0
Household bed net ownership
 Yes, universal coverage 398 79.6
 No 102 20.4
Table 2 Prevalence of symptoms (fever) and specific Plasmodium species by PCR and serology
a Includes two mixed infections, one P. falciparum and P.vivax, one P. knowlesi and P. vivax, therefore total percentages may not equal 100%
n Prevalence (95% CIs) Proportion of current infection (%)
Fever 89 4.9 (3.5–7.1) 3/89 (3.4%)
PCR
 Any Plasmodium species 41 2.6 (1.5–4.3) 100a
 P. falciparum 19 (0.4–3.0) 46.3 (28.7–59.1)
 P. knowlesi 16 (0.5–2.2) 39.0 (21.9–51.3)
 P. vivax 7 0.5 (0.1–2.0) 17.1 (2.2–22.2)
 P. malariae 1 0.04 (0.0–0.4) 2.4 (0–7.08)
Seropositive
 P. falciparum 150 9.4 (6.0–15.0)
 P. vivax 50 3.1 (1.9–6.3)
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compared to 0.003 (0.001–0.006) in those under 23 years 
old. In women, the SCR was similar to that of men under 
23 [0.003 (0.001–0.005)].
Seropositivity to P. vivax antigens was low and SCR 
was also low [0.002 (0.0009–0.006)], with no evidence for 
a change in SCR.
Discussion
This household study reveals low-level malaria transmis-
sion among the general population in central Myanmar. 
The WHO estimates that P. falciparum causes 75% of 
clinical malaria in Myanmar and P. vivax 25% [28], whilst 
in this study P. falciparum mono-infection comprised 
45% of infections and P. vivax 12% (Fig.  2). This study 
found P. knowlesi [29] in more than 35% of positive 
samples. Clinical diagnosis of malaria and most epide-
miological studies in Myanmar use microscopy or RDT 
positivity to identify infection and both RDT and micros-
copy have poor sensitivity and specificity for P. knowlesi 
[30, 31]. In this study, reliable microscopy also proved 
technically challenging. This may explain the underrepre-
sentation of P. knowlesi in national statistics and popula-
tion-level data when compared to the findings presented 
here. In Malaysia, P. knowlesi is responsible for a similar 
proportion of cases as found in this study and can cause 
fatal illness [32]. The epidemiology of P. knowlesi in 
Myanmar requires further study, utilizing sensitive diag-
nostic tools.
One quarter of P. falciparum samples harboured K13 
mutations, all from afebrile, asymptomatic participants, 
none of whom reported anti-malarial treatment within 
the previous three months and none were followed up—
it is therefore difficult to comment on the importance of 
these alleles as determinants of artemisinin susceptibil-
ity. Of the five K13 mutations detected, four have never 
previously been reported. One of the novel mutations, 
Arg539Val, is similar to previously described variants at 
codon 539 from Cambodia, Laos and Myanmar, though 
Table 3 Association between  demographic and  behavioural characteristics and  exposure to  P. falciparum in  study par-
ticipants
a Adjusted for: age, gender, forest exposure, ethnicity, bed net ownership and socio-economic status
Sero-positive (%) Odds ratio (OR) p value Adjusted ORa p value Denominators
Un-weighted Weighted
Gender
 Female 7.1 1.0 (baseline) 1.0 862 871
 Male 12.6 1.9 (1.3–2.8) 0.004 2.1 (1.3–3.4) 0.006 740 731
Age
 0–5 years 0.3 1.0 1.0 162 181
 5–15 years 3.1 9.0 (1.4–58.9) 9.0 (1.3–64.8) 311 292
 15–25 years 3.8 11.2 (1.6–81.5) 12.0 (1.5–94.8) 253 265
 25–50 years 13.0 42.7 (4.0–456.3) 43.8 (3.8–506.3) 541 544
 50–100 years 20.0 71.2 (6.4–796.3) 0.014 71.3 (5.6–904.2) 0.030 335 319
Working in/visiting forests
 No 5.8 1.0 1.0 1454 1454
 Yes 14.7 2.8 (1.5–5.1) 0.002 1.0 (0.6–1.8) 0.979 31 31
Bed net ownership
 Not universal coverage 6.6 1.0 1.0 391 417
 Universal coverage 11.0 1.8 (0.8–3.8) 0.134 1.1 (0.5–2.5) 0.760 1161 1145
Socio-economic status
 Low 11.6 1.0 1.0 506 462
 Medium 11.2 0.9 (0.6–1.5) 0.9 (0.6–1.6) 532 531
 Highest 7.2 0.6 (0.4–0.9) 0.035 0.6 (0.3–0.9) 0.072 512 566
Pf Pv Pk *K13
0 20 6040 80 100%
Pf Pv
a
b
Fig. 2 Proportion of Plasmodium species identified in a our sample 
and b WHO reporting for Myanmar. Pf, P. falciparum; Pv, P. vivax; Pk, P. 
knowlesi. K13 Pf samples with K13 mutations (not available for WHO 
statistics). * 1 × Pf Pv, 1 × Pk Pv, 1 × P. malariae
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these all encode threonine rather than valine as the vari-
ant amino acid [27]. K13 mutations have recently been 
mapped in convenience samples in Myanmar and appear 
prevalent in Upper Myanmar and eastern border areas; 
no K13 mutations were found in a clinical cohort of 52 
patients in Bago Region in 2013–2014 [33], although the 
prevalence of K13 mutations amongst clinical cohorts in 
the high-risk township of Shwe Kyin, Bago, was similar to 
that found in our population [5].
Most participants (n =  38; 93%) with current infec-
tion were afebrile and none reported symptoms. The 
three individuals with raised temperatures tested 
negative on RDT, possibly signifying a low-density par-
asitaemia (or alternative diagnoses) which may be asso-
ciated with mild clinical symptoms [34]. However, even 
sub-clinical infections are important during elimina-
tion campaigns [35]; accurate identification and treat-
ment of asymptomatic carriers—who might transmit 
infections and will tend not to seek treatment—proved 
crucial to eliminate malaria in a similar low-endemic 
setting [36].
The serological data support the PCR data and suggest 
that there has been ongoing low-level transmission of P. 
falciparum and P. vivax in the general population in Bago 
-2.5
-2
-1.5
-1
-.5
0
0 10 20 30 40
Age (years)
0 20 40 60 80
Age, years
a b 
Li
ke
lih
oo
d 
of
 c
ha
ng
e 
in
 S
C
R
 
S
er
op
re
va
le
nc
e 
(%
) 
100 
80 
60 
40 
20 
0 
SCR aged > 23 = 0.028 (0.005-0.155) 
SCR aged < 23 = 0.003 (0.002-0.005) 
Fig. 3 a Profile likelihood plot investigating the most likely age at which a change in seroconversion rate (SCR) occurs in P. falciparum serological 
data and b Seroprevalence curve fitted to P. falciparum with a change in SCR at age 23
0 20 40 60 80
Age, years
S
er
op
re
va
le
nc
e 
(%
) 
100 
80 
60 
40 
20 
0 
S
er
op
re
va
le
nc
e 
(%
) 
100 
80 
60 
40 
20 
0 
SCR aged > 23 = 0.050 (0.010-0.251) 
SCR aged < 23 = 0.003 (0.001-0.006) 
a Males b Females 
SCR = 0.003 (0.001-0.005)
Fig. 4 Seroprevalence curves for P. falciparum a males and b females. The data for males has been fitted with two serconversion rates (SCR), with a 
change at age 23, and the data for females has been fitted with a constant SCR
Page 8 of 10Ghinai et al. Malar J  (2017) 16:16 
region. There was a notable increase in exposure to infec-
tion in men aged over 23, who experience a SCR 16-fold 
higher than the general population. Because the antibod-
ies detected by these methods persist for an unknown 
period of time, there are two explanations indistinguish-
able by serology alone: malaria epidemiology may have 
changed 23  years ago such that men now  aged over 23 
were historically exposed to more malaria, or there may 
be ongoing behavioural risk factors specific to those aged 
over 23. The best working hypothesis is that the change 
in SCR is behavioural; it is confined to a well-defined 
epidemiological group (men of working age) and this 
population is overrepresented in contemporary clinic-
based studies suggesting they remain at increased risk of 
malaria [16].
Forest work is an established risk factor for malaria 
transmission [37]. Plasmodium knowlesi is particularly 
associated with forest malaria, due to the outdoor bit-
ing habits of P. knowlesi vectors and the natural primate 
reservoirs living in forests [38]. The questionnaire cap-
tured self-reported information relating to occupational 
exposure and forest visits. Individuals reporting forest 
exposure were three times more likely to have evidence 
of previous exposure to malaria in the unadjusted anal-
ysis. However, forest workers were significantly more 
likely to be men and aged over 23 and less likely to be 
Indian. After adjusting for other factors including age, 
ethnicity and SES the association with forest exposure 
was no longer significant, which is consistent with for-
est exposure being on the causal pathway (although it 
cannot be excluded that it is a confounder). Illicit forest-
related activities such as illegal logging are often unreli-
ably reported in surveys, and qualitative studies may be 
needed to obtain more information on the spectrum of 
forest exposure as a risk behaviour for malaria in this 
region.
The Myanmar Ministry of Health offers malaria pre-
vention, diagnosis and treatment to the general popu-
lation without distinction. This approach is reflected 
in the high level of bed-net ownership and might con-
tribute to the low levels of transmission observed. 
However, these data suggest that a strategy tailored to 
those at highest risk and with asymptomatic infection 
might be required to eliminate malaria since bed-nets 
will not protect those working in forest plantations at 
dawn and dusk [14]. Targeted interventions have been 
trialed in other areas with varying degrees of success, 
including: insecticide-treated clothing and hammocks 
(for use in the forest); toxic mosquito baits; and per-
sonal insect-repellents [39]. Targeted mass administra-
tion of anti-malarials to specific demographic groups is 
another option [40]. As yet, none have been evaluated 
in Myanmar.
This is the first study in Myanmar to combine detailed 
population-level epidemiological data with highly sensi-
tive molecular techniques. The strength and novelty of 
this study also lie in the size of this probability sample 
from an important but unstudied population, with gen-
eralizability to Bago Region and central Myanmar. How-
ever, higher diagnostic sensitivity has been achieved with 
the technique of high volume ultra-sensitive qPCR [16] 
though this requires collection of larger blood volumes 
by venepuncture, and an unbroken cold-chain for trans-
port of packed red cells to a specialist molecular biology 
laboratory. Point prevalence of current infection is sensi-
tive to seasonal variation, and this study was conducted 
towards the end of the rains—regarded as the malaria 
high season—to sample at the peak of malaria transmis-
sion (though different seasonal peaks have been reported 
for some areas nearby [41, 42]). Moreover, others report 
little by way of seasonal variation [43], and by correlating 
PCR findings with serology, which is less sensitive to sea-
sonal changes, robust hypotheses can be developed. The 
study aimed to minimize bias in this population-based 
study by weighting the sample so that it was broadly rep-
resentative of national demographic data in Myanmar 
in terms of gender and age [44], but the sampling strat-
egy excluded the population living closest to the flooded 
Sittang River due to adverse weather conditions, which 
made these areas inaccessible, and where malaria trans-
mission might be higher. In addition, the ethnic composi-
tion of this sample differs from national averages because 
ethnicity in Myanmar is clustered [44]; the sample over-
represented Indian participants (33% compared to 2% in 
national statistics) and underrepresented Shan (3% com-
pared to 9%). One-fifth of residents were absent during 
study visits, and these individuals were more likely to be 
male and less likely to be of Indian origin, and this house-
hold survey did not include hospital in-patients being 
treated for malaria. We were only able to provide popu-
lation weighting at the ward level due to a lack of avail-
able population statistics for individual villages. In our 
experience, village sizes did vary, though it is unlike that 
this would have affected our prevalence estimates, given 
the ward-level weighting applied and the small number 
of infections detected. The overall effect of our diagnostic 
techniques and sampling strategy is that the study design 
might have underestimated rather than overestimated 
malaria prevalence.
Conclusion
Malaria transmission in this area was low. However, there 
were low numbers of asymptomatic carriers who prob-
ably play an important role in maintaining local trans-
mission, and many were infected with P. knowlesi. A 
higher proportion of K13 mutations among P. falciparum 
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cases were observed than has previously documented in 
this region, and working age men appear at significantly 
higher risk of malaria exposure when compared to the 
general population, which needs further research. How-
ever, the public health implications are clear; the WHO 
goal of malaria elimination in this region will require 
identification and treatment of asymptomatic carriers 
among high-risk populations in order to control arte-
misinin resistance and successfully eliminate malaria in 
this setting.
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